Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
-
New pill shows promise against hard-to-treat lymphoma
Disease control CompletedThis study tested an oral drug called AZD4205 in 57 adults with peripheral T-cell lymphoma that returned or didn't respond to at least one prior therapy. The goal was to see if the drug could shrink tumors and how safe it was. Participants took one pill daily, and researchers mea…
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Healthy men help scientists track how a lymphoma drug leaves the body
Knowledge-focused CompletedThis study looked at how healthy men absorb, break down, and eliminate a drug called DZD8586, which is being developed for non-Hodgkin lymphoma. Six healthy male volunteers took a single dose with a tiny radioactive marker so scientists could track it in blood, urine, and stool. …
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 08:30 UTC